Guardion Health Sciences, Inc. Common Stock
GHSI
GHSI was delisted on the 11th of October, 2024.
13 hedge funds and large institutions have $387K invested in Guardion Health Sciences, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
300% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 1
30% more funds holding
Funds holding: 10 → 13 (+3)
23% more capital invested
Capital invested by funds: $314K → $387K (+$73K)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$13.8K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$270 |
| 3 |
RMA
Roffman Miller Associates
Philadelphia,
Pennsylvania
|
+$251 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Barclays
London,
United Kingdom
|
-$25.8K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $293K | +$13.8K | +2,200 | +6% |
|
2
BlackRock
New York
| $78K | – | – | – |
|
|
3
Barclays
London,
United Kingdom
| $7K | -$25.8K | -4,100 | -82% |
|
4
Morgan Stanley
New York
| $5.13K | – | – | – |
|
5
Citigroup
New York
| $2.84K | – | – | – |
|
|
6
UBS Group
Zurich,
Switzerland
| $335 | +$270 | +43 | New |
|
|
RMA
7
Roffman Miller Associates
Philadelphia,
Pennsylvania
| $311 | +$251 | +40 | New |
|
|
CPG
8
Cornerstone Planning Group
Fairfield,
New Jersey
| $288 | +$232 | +37 | New |
|
|
S
9
SignatureFD
Atlanta,
Georgia
| $156 | – | – | – |
|
|
FDCDDQ
10
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $132 | – | – | – |
|
|
IPW
11
Impact Partnership Wealth
Marietta,
Georgia
| $78 | +$63 | +10 | New |
|
12
Wells Fargo
San Francisco,
California
| $70 | – | – | – |
|
13
Osaic Holdings
Scottsdale,
Arizona
| $47 | – | – | – |
|
GHSI Hedge Fund Activity: Q2 2023 in Review
13 of the 6,371 institutional investors tracked by Wall St. Rank reported a position in Guardion Health Sciences, Inc. Common Stock (GHSI) for Q2 2023, worth a combined $387K — up 23% from $314K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new GHSI positions and 1 closed out — a net gain of 3 holders — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $13.8K. The largest seller was Barclays, cutting an estimated $25.8K.
- 13 institutional investors held Guardion Health Sciences, Inc. Common Stock (GHSI) as of Q2 2023, up from 10 in Q1 2023.
- Funds reported $387K of Guardion Health Sciences, Inc. Common Stock stock for Q2 2023, up 23% quarter-over-quarter.
- 4 funds opened new Guardion Health Sciences, Inc. Common Stock positions in Q2 2023 and 1 closed out, a net change of +3 holders.
- The largest Guardion Health Sciences, Inc. Common Stock buyer in Q2 2023 was Renaissance Technologies, an estimated $13.8K added.
- The largest Guardion Health Sciences, Inc. Common Stock seller in Q2 2023 was Barclays, an estimated $25.8K sold.
Based on aggregated 13F filings for Q2 2023.